Clinical Trial

Biomarkers in Pediatric Inflammatory Rheumatic Diseases

Study acronym: BIRPED
Completed
View on ClinicalTrials.gov →
Summary
A prospective study is proposed to serially determine new biomarkers: Calprotectin and Serum Amyloid Protein, alongside 'conventional' biomarkers: CRP and ESR, to help evaluate their utility in routine clinical practice
Trial Details
NCT Number NCT07356804
Lead Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Conditions Juvenile Idiopathic Arthritis, Flare Up, Symptom
Enrollment 20 participants
Start Date 2018-09-05
Primary Completion 2019-12-30 (estimated)
Study Completion 2020-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-21